Company

Isomab Ltd

Biotechnology Research Biocity, United Kingdom 13 employees

Employees: 13
Contacts: 3
Emails: 3
Phones: 2

www.isomab.bio LinkedIn Crunchbase

Isomab Ltd Overview

Headquarters: Biocity, United Kingdom
Website: www.isomab.bio
Industry: Biotechnology Research
Employees: 13
Founded: 2022
Funding: 9.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

jobs

About Isomab Ltd

IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease.

Isomab Ltd Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Isomab Ltd Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tom Needham	Biotech Vc Investor - Broadview	Greater Boston, United States	Email Phone
Anker Lundemose		Cambridge, England, United Kingdom	Email Phone
Amanda Pujolas	Executive Assistant at Isomab Ltd	London Area, United Kingdom	Email
Dr Kishor Modha	Senior Cmc Consultant - Programme		View